Cargando…
Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy
Following the previously published results of the clinical randomized ZeOxaNMulti trial, we evaluated the potential of the tested product PMA-ZEO (Multizeo Med) in the prevention of chemotherapy-induced side effects (especially peripheral neuropathy) within a 30-month follow-up analysis. The aim was...
Autores principales: | Vitale, Maria Giuseppa, Crispo, Anna, Arundine, Dario, Ronga, Riccardo, Barbato, Carmela, Luongo, Assunta, Habetswallner, Francesco, De Martino, Bernardo Maria, Maione, Angela, Eisenwagen, Sandra, Vitale, Giovanna, Riccardi, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680527/ https://www.ncbi.nlm.nih.gov/pubmed/36425572 http://dx.doi.org/10.3389/fphar.2022.874028 |
Ejemplares similares
-
ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy
por: Vitale, Maria Giuseppa, et al.
Publicado: (2020) -
Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial
por: Kraljević Pavelić, Sandra, et al.
Publicado: (2022) -
Etymologia: Babesia [bə-be′ ze-ə]
Publicado: (2009) -
Counting mitoses: SI(ze) matters!
por: Cree, Ian A., et al.
Publicado: (2021) -
Mantelzorgers: (H)erken jij ze?
por: Vermunt, Ellen
Publicado: (2022)